PFP7-28-2023 : simplebooklet.com

Pathology Free PressPathology Free PressPathology Free PressOn Tuesday, July 25th, Loyola hosted Mike Slubowski, President and Chief Executive Officer of Trinity Health. As part of this visit, Mr. Slubowski, along with Loyola Medicine executive team toured our laboratories. As Shawn Vincent, President & CEO, Trinity Health Illinois/Indiana Region has said; " Mike was very impressed with the lab". Even during this short interaction we were able to show how much we care about our patients and, most importantly, that we are good and responsible stewards of our resources.From left to right: Richard Freeman, MD, MBA, FACS, Regional Chief Clinical Officer, Shawn P. Vincent President and CEO, Loyola Medicine, Dr. Eva Wojcik, M.D. Chair, Department of Pathology and Laboratory Medicine and Medical Director, Regional Laboratory, Michael A. Slubowski, FACHE, FACMPE, President and Chief Executive Officer of Trinity Health, Jonathan Bakst, Regional Administrative Director Laboratory Services and Melissa Lukasick, MBA Regional Chief Financial OfficerJack A. Maggiore, PhD, Medical Director, Regional Core Laboratory Regional Director, Point of Care Testing with Trinity Health senior leadership

Page 3

Pathology Free PressPathology Free PressPathology Free PressWe are excited to provide an update on the inaugural awards from the Paul Schreckenberger Memorial Fund!The first award went to Jennifer Paddack, MLS, M(ASCP)CM, who is a medical laboratory scientist in the microbiology lab at Loyola University Medical Center. She applied for funds to attend ASM Microbe, which is an international microbiology meeting held annually. Jenny provided a brief summary and a few pictures from the meeting:“I had the opportunity to attend the annual American Society for Microbiology conference (ASM Microbe) in Houston, Texas last month. The conference was a great experience and included full days of lectures, discussions, poster sessions, live podcasts, and exhibits. ASM did an incredible job showcasing the latest and emerging research in various sectors of microbiology. There were many interesting presentations on a wide range of topics from emerging infectious diseases to using microorganisms as solutions to climate change. My favorite presentations included topics related to diagnostic mycology, antimicrobial resistance, new therapeutic treatments in the pipeline, and public health. Specifically, I found interest in the presentations that discussed current research on phage therapy. At a glance, phage therapy seems like an optimistic solution to treating MDRO infections, however, I learned that researchers are still working to elucidate the interactions between phages and antibiotics and how this may affect clinical outcomes. I also learned that exposure to specific antibiotics can affect phage phenotypes and have both synergistic and antagonistic effects on phage activity, including phage production and phage resistance.Each presentation was thought-provoking, engaging, and ultimately served as a source of inspiration to continue learning and growing as a microbiologist. Thank you to Dr. Harrington, Erin, and the Schreckenberger Memorial Fund for this wonderful opportunity."

Page 4

Pathology Free PressPathology Free PressThe second award went to Sandra Haddad, MD and Constantine "Aki" Kanakis MD, MSc, MLS(ASCP)CM, PGY4 residents who are our inaugural Chief Residents for Quality this academic year. Dr. Haddad will be working with Dr. Barroeta, AP Quality Medical Director, and focusing on projects to improve the turnaround time and documentation for surgical and autopsy reports, to ensure we are following the most recent CAP guidelines for staging summaries, and to provide educational sessions on quality. Dr. Kanakis will be working with Dr. Harrington, CP Quality Medical Director, and focusing on Hospital Education on Laboratory and Pathology Processes Program (Project HELPPP), which is a new interdisciplinary initiative that aims to address challenges to laboratory testing before they happen. The project will work to take an inventory of knowledge gaps in clinical processes, establish a reliable laboratory testing and operations curriculum, and collate pre-and-post data regarding pre-analytical error reduction with the overall goal of improving the understanding of clinical laboratory requests, improving relationships with our clinical colleagues, and increasing effective test utilization and stewardship.Sandra Haddad, MDAP Quality Constantine “Aki” Kanakis, MDCP Quality The application period for the Schreckenberger Fund award is now open. Please see the following announcement information to apply: The Paul Schreckenberger, PhD Memorial Fund Paul C. Schreckenberger, PhD, D(ABMM), F(AAM), was a world renowned microbiologist and life-long scholar who dedicated his life to mentoring, supporting and furthering the mission of professionals in the medical laboratory sciences. Dr. Schreckenberger served as the Director of the Clinical Microbiology Laboratory at Loyola University Medical Center and a Professor of Pathology and Laboratory Medicine from 2005 until his passing in 2016. Established in 2017, the endowed Paul Schreckenberger, PhD Memorial Fund continues his life's mission and furthers his legacy by supporting Loyola’s Department of Pathology and Laboratory Medicine. This fund will be used to advance the skills of medical laboratory scientists (MLS) and laboratorians at Loyola Medicine through funding for research, professional development, and continuing education (CE). Direct application of these funds will help enhance training in laboratory quality and management, applied technology, and research and continue preparation to meet the constantly expanding needs and challenges of the laboratory science profession. Resources for this memorial fund originate from donations from generous colleagues, friends, industry partners, professional societies and loving support from the Schreckenberger family, who honor Dr. Schreckenberger’s lifelong commitment to education. Eligibility: Medical laboratory scientists currently employed with Loyola Medicine laboratories; resident physicians in Pathology and Laboratory Medicine; (MLS master’s program students are not currently eligible). Application Period: Applications will be reviewed and awarded Aug 1-Mar 30 on a first come, first served basis. Awards: (Annual Total $3400) $2400 reserved for MLS—can be used for professional meeting attendance or continuing education courses (registration, flight, hotel, mileage; does not include food or additional expenses), or research support; Awards can be applied for in advance of abstract acceptance but not before submission.

PFP7-28-2023

Page 1

Page 2

Page 3

Page 4

Page 5

Page 6

Page 7

Page 8

Page 9